| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1063-4584(98)80005-8 |
| P698 | PubMed publication ID | 9743813 |
| P2093 | author name string | J M Williams | |
| J Zhang | |||
| D Uebelhart | |||
| E J Thonar | |||
| P2860 | cites work | Reversible collapse of rabbit ears after intravenous papain, and prevention of recovery by cortisone | Q36263240 |
| Collagen synthesis in normal and osteoarthritic human cartilage | Q37043661 | ||
| Correlation between articular cartilage collagenase activity and osteoarthritis | Q40176912 | ||
| Increased fixation of sulfur-35 by cartilage in vitro following depletion of the matrix by intravenous papain | Q42132850 | ||
| Quantification of keratan sulfate in blood as a marker of cartilage catabolism | Q42203470 | ||
| The relative toxicity of nonsteroidal antiinflammatory drugs | Q44117748 | ||
| Elevation in urinary levels of pyridinium cross-links of collagen following chymopapain-induced degradation of articular cartilage in the rabbit knee provides evidence of metabolic changes in bone | Q47969978 | ||
| Alteration and recovery of the spatial orientation of the collagen network of articular cartilage in adolescent rabbits following intra-articular chymopapain injection. | Q50753916 | ||
| Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. | Q50904346 | ||
| Increase in levels of serum keratan sulfate following cartilage proteoglycan degradation in the rabbit knee joint | Q70051511 | ||
| Further characterization of a neutral metalloprotease isolated from human articular cartilage | Q70260686 | ||
| Repair of articular cartilage injury following intra-articular chymopapain-induced matrix proteoglycan loss | Q70506550 | ||
| Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop | Q73116677 | ||
| EXPERIMENTALLY INDUCED ARTHRITIS USING INTRA-ARTICULAR PAPAIN | Q76852486 | ||
| P304 | page(s) | 6-13 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Osteoarthritis and Cartilage | Q7107605 |
| P1476 | title | Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit | |
| P478 | volume | 6 Suppl A |
| Q37951364 | Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule |
| Q36713898 | Chondroitin sulfate as a structure-modifying agent |
| Q36713902 | Chondroitin sulfate in the management of erosive osteoarthritis of the interphalangeal finger joints |
| Q36059429 | Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. |
| Q34285595 | Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? |
| Q46032045 | Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro. |
| Q44376296 | Current management of osteoarthritis. Part 1: pharmacological strategies |
| Q36230822 | Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study |
| Q36713889 | Effects of chondroitin sulfate on the cellular metabolism |
| Q41773636 | Effects of gangliosides from deer bone extract on the gene expressions of matrix metalloproteinases and collagen type II in interleukin-1β-induced osteoarthritic chondrocytes |
| Q34109134 | Evidence of nutriceutical effectiveness in the treatment of osteoarthritis |
| Q79319417 | Glucosamine and chondroitin for osteoarthritis: to recommend or not to recommend? |
| Q42330053 | Glucosamine and chondroitin for the treatment of osteoarthritis |
| Q35121454 | Glucosamine and chondroitin sulfate are effective inthe management of osteoarthritis |
| Q24805719 | Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report |
| Q44439622 | Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress |
| Q33994668 | Immunological activity of chondroitin sulfate |
| Q80676023 | Intra-articular delivery of chondroitin sulfate for the treatment of joint defects in rabbit model |
| Q36374283 | Medical treatment of osteoarthritis in the horse - a review |
| Q34978132 | New Frontiers for Cartilage Repair and Protection |
| Q38274507 | Serum keratan sulfate transiently increases in the early stage of osteoarthritis during strenuous running of rats: protective effect of intraarticular hyaluronan injection. |
| Q24558762 | Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repair |
| Q35652515 | Structure-modifying agents for osteoarthritis: an update |
| Q34168456 | Therapeutics for rabbits |
| Q84600460 | [Do disease modifying drugs exist for osteoarthritis] |
Search more.